Last C$0.50 CAD
Change Today 0.00 / 0.00%
Volume 0.0
As of 3:54 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

ergoresearch ltd (ERG) Snapshot

Open
C$0.54
Previous Close
C$0.60
Day High
C$0.54
Day Low
C$0.46
52 Week High
08/26/14 - C$1.02
52 Week Low
03/2/15 - C$0.46
Market Cap
37.5M
Average Volume 10 Days
28.0K
EPS TTM
C$0.02
Shares Outstanding
75.8M
EX-Date
--
P/E TM
30.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for ERGORESEARCH LTD (ERG)

Related News

No related news articles were found.

ergoresearch ltd (ERG) Related Businessweek News

No Related Businessweek News Found

ergoresearch ltd (ERG) Details

Ergoresearch Ltd., through its subsidiaries, manufactures and sells custom foot and general orthotics. It also develops medical equipment for the orthopedic market. The company offers OdrA distraction orthotic device that provides knee mobility by decreasing pain-causing intra-articular pressure; custom fit 3D foot orthotics; motor-powered prosthesis power knee, a motor-powered prosthesis for above-knee amputees; and WebFit system that includes a podo-barometric sensor pad, an optical scanner, and clinical software. It offers services and specialty orthotics in 13 laboratories and approximately 70 satellite offices operating under the Équilibre brand in Quebec. The company was formerly known as Ergo Ventures Inc. and changed its name to Ergoresearch Ltd. in February 2003. Ergoresearch Ltd. was incorporated in 2001 and is headquartered in Laval, Canada.

Founded in 2001

ergoresearch ltd (ERG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$60.0K
Vice-President of Operations
Total Annual Compensation: C$90.0K
Director of Laboratory, Director and Vice Pre...
Total Annual Compensation: C$70.0K
Compensation as of Fiscal Year 2014.

ergoresearch ltd (ERG) Key Developments

Ergoresearch Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2014

Ergoresearch Ltd. reported earnings results for the first quarter ended September 30, 2014. For the quarter, the company’s revenues amounted to CAD 4,137,111 compared with CAD 4,227,942 for the same period in the last year. This decrease is partly related to the following elements: The closing of a laboratory located in Laval (Podotech). All activities and patients files were transferred to the Équilibre Laval branch. The transition period required to merge all the banners of the group (Laboratoire Langelier, Laboratoire Podotech, Clinique du Pied Équilibre et Orthoconcept) into one unified banner. Net income after tax was CAD 308,431 compared with CAD 336,113 for the same period in the last year. Cash flow from operating activities was CAD 872,259 compared with CAD 63,576 a year ago. EBITDA was CAD 673,270 compared with CAD 711,496 a year ago. Net income before tax reached CAD 400,431 compared to CAD 433,948 for the same period last year.

Ergoresearch Ltd. Announces Management Changes

Ergoresearch Ltd. announced the appointment of Mrs. Dominique Boudreau who will hold the position of Vice-Président Finance among its management team. Mrs. Dominique Boudreau was acting as corporate controler of the group since January 2013 and occupied similar duties for more than seven years for Laboratoire Langelier, a company acquired by the Ergioresearch Ltd. in January 2013. Mrs. Boudreau replaces Mr. Greco who was previously appointed Chief Financial Officer in April 2014. Mr. Greco left to pursue new goals.

Ergoresearch Ltd., Annual General Meeting, Dec 19, 2014

Ergoresearch Ltd., Annual General Meeting, Dec 19, 2014., at 10:00 US Eastern Standard Time. Location: Ergoresearch complex building. Agenda: To receive and review the management report, the audited financial statements and the auditors' report thereon for the twelve month period ended on June 30, 2014; to elect a board of directors for the ensuing year; to appoint the auditor of the company for the ensuing year and to authorize the board of directors to fix the auditor's remuneration; to transact any such other business as may properly be brought before the Meeting or any adjournment thereof.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ERG:CN C$0.50 CAD 0.00

ERG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ERG.
View Industry Companies
 

Industry Analysis

ERG

Industry Average

Valuation ERG Industry Range
Price/Earnings 32.7x
Price/Sales 2.3x
Price/Book 1.4x
Price/Cash Flow 33.2x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ERGORESEARCH LTD, please visit www.ergoresearch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.